COVID-19 in patients with hidradenitis suppurativa.

Lima, X T; Cueva, M A; Alora, M B

Lima, X T; Cueva, M A; Alora, M B.

Lima XT; Massachusetts General Hospital, Clinical Unit for Research Trials in Skin, Boston, MA, USA.
Cueva MA; Dermatology Division, Internal Medicine Department, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Alora MB; Massachusetts General Hospital, Clinical Unit for Research Trials in Skin, Boston, MA, USA.

Br J Dermatol ; 184(1): 182-184, 2021 01.

Article in English | MEDLINE | ID: covidwho-717287

Subject(s)

COVID-19/diagnosis; Hidradenitis Suppurativa/immunology; SARS-CoV-2/immunology; Adult; Age Factors; Aged; Boston/epidemiology; COVID-19/epidemiology; COVID-19/immunology; COVID-19/therapy; Comorbidity; Diabetes Mellitus/epidemiology; Diabetes Mellitus/immunology; Female; Hidradenitis Suppurativa/epidemiology; Hospitalization/statistics & numerical data; Humans; Hypertension/epidemiology; Hypertension/immunology; Male; Middle Aged; Obesity/epidemiology; Obesity/immunology; Protective Factors; Retrospective Studies; Risk Factors; SARS-CoV-2/isolation & purification; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hidradenitis Suppurativa / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: Br J Dermatol Year: 2021 Document Type: Article Affiliation country: Bjd.19492

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google